Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-03 Option Award | 2024-01-05 4:41 pm | N/A 2034-01-02 | Tempest Therapeutics Inc. | TPST | Brady Stephen R President and CEO | 250,000 | $0 | 250,000 (Direct) | View |
| 2023-10-11 Option Award | 2023-10-13 4:41 pm | N/A 2033-10-10 | Tempest Therapeutics Inc. | TPST | Brady Stephen R President and CEO | 725,000 | $0 | 725,000 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:06 pm | N/A 2023-06-12 | Atreca Inc. | BCEL | Brady Stephen R Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 8:00 pm | N/A 2033-01-02 | Tempest Therapeutics Inc. | TPST | Brady Stephen R Chief Executive Officer | 177,300 | $0 | 177,300 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-22 4:29 pm | N/A 2032-06-20 | Tempest Therapeutics Inc. | TPST | Brady Stephen R Chief Executive Officer | 173,533 | $0 | 173,533 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-10 6:46 pm | N/A 2032-06-07 | Atreca Inc. | BCEL | Brady Stephen R Director | 12,000 | $0 | 12,000 (Direct) | View |
| 2022-01-04 Option Award | 2022-01-06 7:23 pm | N/A 2032-01-03 | Tempest Therapeutics Inc. | TPST | Brady Stephen R Chief Executive Officer | 94,500 | $0 | 94,500 (Direct) | View |
| 2021-07-14 Option Award | 2021-07-16 7:39 pm | N/A 2031-07-13 | Atreca Inc. | BCEL | Brady Stephen R Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2021-06-25 Option Award | 2021-06-29 9:54 pm | N/A 2029-09-15 | Millendo Therapeutics Inc. | TPST | Brady Stephen R Chief Executive Officer | 2,170,988 | $0 | 2,170,988 (Direct) | View |